Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search Materials

A library of resources for the prevention,
management, and elimination of TB.

Showing 1 - 15 of 98 Results

Number of items to view
Filter Your Results
Title Year

This report discusses the relationship between TB and sustainable development, and advocates for increased dialogue and action among TB partners.

International Agencies
2000

This booklet explains the relationship between MDR-TB, DOTS, and DOTS-Plus and how projects can become a DOTS-Plus pilot project that can benefit from concessionary prices negotiated for second-line anti-TB drugs by the Working Group.

Managers and Supervisors
2000

This monograph discusses the history of TB, the search for TB treatment and diagnostic methods, and its resurgence, including the emergence of multiple drug resistant (MDR) strains of TB.

2001

This book describes the technical framework and principles used to implement DOTS-Plus in resource poor settings. It also provides a number of case histories that illustrate common challenges in the treatment of MDR TB patients. The book includes protocols that can be used under DOTS-Plus program conditions to manage common complication of this therapy.

2002

These guidelines have been developed to assist national TB control programs (NTPs) in adopting specific anti-TB drug resistance surveillance systems to measure susceptibility to first-line TB drugs.

International Agencies
2003

This pocket guide is intended to be a resource for physicians and other health care professionals who provide care and treatment to patients with MDR TB in DOTS-Plus projects.

2003

This report presents recommendations for the treatment of tuberculosis.

2003

This video summarizes the key elements of the multi-faceted, private-public partnership that has been assembled by Lilly to meet the challenge of MDR-TB. Several world-recognized experts from academia, international agencies, and from within the company talk about the challenges that developing nations face in implementing sound containment programs given the lack of awareness, adequately trained personnel and access to affordable drugs.

Managers and Supervisors
2004

This manual provides practical guidance relating to the proper use of ambulatory infusion therapy for the treatment of MDR-TB. The guide offers a rationale for providing outpatient infusion therapy for MDR-TB in a clinic setting and describes how to organize the clinic to provide the therapy. In addition, it contains a wall chart which summarizes the daily tasks for providing infusion therapy.

Managers and Supervisors
2004

This guide provides the clinical and epidemiological aspects of tuberculosis in the context of the National Tuberculosis Programme (NTP) in 18 illustrated chapters. This guide is a comprehensive reference for anyone involved in the treatment, control, and prevention of tuberculosis and is especially geared to specialist physicians working in low-income countries.

2004

This manual has been written with the aim of developing the knowledge, awareness, and skills of primary health care providers. Primary health care providers can play an important role in tuberculosis control through early detection of the disease, referral for treatment, and involvement in directly observed therapy...

2004

This fact sheet clarifies the major differences of tuberculosis treatment guidelines between national and California recommendations.

2004

This book provides a basis for the diagnosis and management of tuberculosis. It is presented in a question-and-answer format, with subject matter grouped under the three headings: Case Detection, Treatment, and Monitoring.

Managers and Supervisors Policy Makers
2004

This report describes the progress of the Stop TB Partnership. It reports that TB control is succeeding around the world. The challenges include increasing and sustaining new funding levels; strengthening the public health system, including the availability, capacity, and motivation of human resources; empowering households and communities; engaging providers in the private and other sectors; and creating and adopting new technology, such as diagnostics, drugs, and vaccines.

International Agencies Managers and Supervisors Policy Makers
2004

This report describes the distribution of TB cases among the population of California and the demographic and clinical characteristics of TB cases in 2003. It presents the risk factors for TB, drug resistance, treatment outcomes of the reporting jurisdictions in California, and recent trends.

Managers and Supervisors Policy Makers
2005